How to Participate in a COVID-19 Vaccine Clinical Trial
A phase III clinical trial for the vaccine produced by Moderna is seeking 30,000 participants across the country.
Category: Clinical Trials
From Lab to Bedside: How Clinical Trials Work
Here’s how clinical trials help advance our understanding of medicine.
A Mother’s Quest to Help Her Son Hear
Clinical Trials, Ear, Nose, and Throat, Health, Hearing, UNC Children's, UNC Stories
Cancer Clinical Trials Don’t Have to Be a Last Resort
Learn how you can play a more active role in your treatment and help other patients, too.
‘Conversations with Innovators:’ UNC hematologist on promising drug...
Kenneth Ataga, MD, director of the UNC Comprehensive Sickle Cell Program, was featured in a video by the American Society of Hematology in which he discussed the favorable results of a yearlong clinical trial studying crizanlizumab as a therapy to prevent and treat painful crisis events in patients with sickle cell disease.
The purist: Chapel Hill man shares journey of HIV clinical trials a...
Robert Hill has been living with HIV for 22 years. Five years ago, he enrolled in a study at the UNC School of Medicine, which was part of Dr. David Margolis’ ‘kick and kill’ strategy for eradicating HIV by flushing it out of hiding with a drug called Vorinostat and killing it with either a vaccine
‘To seek a true cure’: UNC researchers pioneer HIV research w...
In honor of World AIDS Day on Dec. 1, we take a look at the trailblazing ‘kick and kill’ method of attacking HIV to cure patients. UNC researchers have been working with GlaxoSmithKline on parallel studies at the UNC Cure Center for 18 months to advance this new method of combating the global epidemic of HIV.
New study questions clinical trial data for kidney cancer drugs
Participants in stage IV renal cell cancer drug trials are younger and healthier than many patients who don’t qualify for research studies.
New UNC Lineberger faculty recruited to launch T-cell cancer therap...
Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials that will test an experimental treatment in which patients’ own immune cells are genetically engineered to fight their cancer.
Two UNC doctors participating in Ebola clinical trial
William A. Fischer II and David Wohl are taking part in a clinical trial at ELWA Hospital in Monrovia, Liberia, in which plasma from survivors of Ebola virus disease is given to patients who are battling the disease.
War vet receives his hearing back
Dr. Oliver Adunka, an ENT surgeon at UNC Health Care, was able to get Dac Carpenter into a clinical trial that installed a sound bridge in one ear. That allows Dac to hear just like he did before he was injured.
Building a Better Image
Andrew Tucker, PhD, used his graduate experience at UNC to help build a new kind of mammographic imaging machine now in use in a clinical trial at the North Carolina Cancer Hospital.